Scinai Immunotherapeutics Ltd. American Depositary Shares Gains 45.07%
Mon, Jul 15, 2024 at 07:09 PM
Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI:NASDAQ) jumped higher at $5.89, a gain of 45.1%. On Mon, Jul 15, 2024, SCNI:NASDAQ touched a New 2-Week High of $5.89. The stock got featured on our News Catalysts scanner on Mon, Jul 15, 2024 at 01:38 PM in the 'ACQUISITION' category. From Mon, Jul 01, 2024, the stock recorded 66.67% Up Days and 60.00% Green Days
The stock spiked on Mon, Jul 15, 2024 at $8.92 with a volume of 29M+.
About Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI:NASDAQ)
BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine.
Top 10 Gainers:
- Autonomix Medical Inc. (AMIX:NASDAQ), 130%
- DatChat Inc. (DATS:NASDAQ), 78.3%
- AEON Biopharma Inc. Class A (AEON:NYSEMKT), 62.86%
- Cyngn Inc. (CYN:NASDAQ), 53.77%
- Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI:NASDAQ), 45.07%
- Sadot Group Inc Com (SDOT:NASDAQ), 36.72%
- Trump Media & Technology Group Corp Cl A (DJT:NASDAQ), 31.37%
- Gauzy Ltd. (GAUZ:NASDAQ), 29.3%
- Cipher Mining Inc. (CIFR:NASDAQ), 27.78%
- Stardust Power Inc Com (SDST:NASDAQ), 25.56%